![THU0441 Effect of Concomitant Conventional Disease-Modifying Antirheumatic Drugs (cDMARDs) on The Efficacy and Safety of Ixekizumab in Biologic Dmard-Naive Patients with Active Psoriatic Arthritis]()
THU0441 Effect of Concomitant Conventional Disease-Modifying Antirheumatic Drugs (cDMARDs) on The Efficacy and Safety of Ixekizumab in Biologic Dmard-Naive Patients with Active Psoriatic ArthritisCoates, L.C.; Gottlieb, A.B.; Shuler, C.L.; Lin, C.-Y.; Samanta, S.; Moriarty, S.R.; Lee, C.H.; Mease, P.J. · Annals of the Rheumatic Diseases · 2016